Antiviral OTC Medications

Combined Synopsis/SolicitationSmall BusinessActive

Key Takeaways

  • Set-aside for Small Business businesses
  • Work to be performed in MINNEAPOLIS, MN
  • Industry: Pharmaceutical Preparation Manufacturing

Contract Details

Notice ID
12639526Q0214
Opportunity Type
Combined Synopsis/Solicitation
Sub-Agency
ANIMAL AND PLANT HEALTH INSPECTION SERVICE
Office
MRPBS MINNEAPOLIS MN
Posted Date
Thursday, July 9, 2026
Response Deadline
Friday, July 17, 2026
PSC Code
6505
Place of Performance
MINNEAPOLIS, MN, 55401
Status
Active

Description

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Part 12. This announcement constitutes the only solicitation. Quotations are being requested and a separate written solicitation will not be issued. Solicitation number 12639526Q0214 is issued as a Request for Quotation (RFQ) for the following antiviral medications: Zanamivir (Relenza) inhalation powder Oseltamivir (Tamiflu) oral antiviral capsules This acquisition is set-aside for small business concerns. The applicable North American Industry Classification Standard Code is 325412. The small business size standard is 1,300 employees. This acquisition is a Total Small Business Set-Aside. All responsible sources may submit a quotation which will be considered by the agency.

Why This Opportunity Matters

AGRICULTURE, DEPARTMENT OF is actively seeking qualified contractors for pharmaceutical preparation manufacturing with a set-aside for Small Business businesses in MINNEAPOLIS, MN. This set-aside designation means eligible businesses face reduced competition from larger firms.